SLC5A2 and atherosclerosis: Additionally, SGLT2 inhibitors can delay the aging of endothelial cells and smooth muscle cells, reduce inflammation and oxidative stress, regulate the expression of MicroRNA and prevent the occurrence and development of atherosclerosis, and can improve blood vessel stiffness and aging.